Skip to main content

Table 1 Clinical details of all patients

From: Pulmonary function changes after sublobar resection in patients with peripheral non-subpleural nodules

 

Wedge resection

Segmentectomy

P value

n

46

42

 

Age (year)

46.9 ± 13.0

46.5 ± 12.2

0.724

Gender

0.583

 Female

30

24

 

 Male

16

18

 

Preoperative imaging diagnosis

0.426

 Pure GGN

30

32

 

 Mixed GGN

16

10

 

Target lung segment

 

 S1

 

6

 

 S1+2

 

14

 

 S4+5

 

4

 

 S6

 

10

 

 S9+10

 

8

 

Intraoperative frozen section diagnosis

 

 AHH

0

0

 

 AIS

34

28

 

 MIA

6

6

 

 IAC

0

0

 

 Benign lesion

6

8

 

Tumor diameter

12.4 ± 3.6

10.2 ± 4.6

0.095

Distance from nodule to pleura (Mm)

24.0 ± 5.4

28.1 ± 11.8

0.347

Smoking history

 

 Yes

4

4

 

 No

42

38

 

Duration of surgery (min)

70 ± 22

111 ± 52

0.0002***

Postoperative drainage (mL)

85 ± 45

287 ± 672

0.0123*

Air leak time (days)

1.7 ± 0.7

2.5 ± 1.7

0.062

Length of hospitalization (days)

2.7 ± 0.7

3.5 ± 1.7

0.051

Complication

0

0

 

Pathological type

 AHH

0

2

 

 AIS

34

26

 

 MIA

6

6

 

 IAC

0

0

 

 Benign lesion

6

8

 

Treatment and hospitalization expenses (CNY)

35,148 ± 889

52,502 (38,276–57,772)

0.0002***

  1. Wedge resection has a shorter duration of surgery, less postoperative drainage and less hospitalization cost than segmentectomy. No significant differences were detected between two groups in the air leak time and hospitalization time. No significant difference was found in the distance from nodule to pleura between the two groups, indicating that the depth of pulmonary nodules was similar between the two groups. The length of stapler trace on chest CT 3 months after operation was measured for each patient, traces of staplers on chest CT scan were relatively more obvious when patients who underwent segmental pneumonectomy came for review 3 months after operation
  2. AHH atypical adenomatous hyperplasia, AIS adenocarcinoma in situ, MIA minimally invasive adenocarcinoma, IAC invasive adenocarcinoma cancer